Immunogenicity of Vaccines Against SARS-CoV-2 In Patients With Rheumatic Diseases

Белов, Б. С.; Muravyeva, N. V.; Kulikov, A. N.

doi:10.37489/0235-2990-2022-67-5-6-70-80

A&Ch

2022

DOI: 10.37489/0235-2990-2022-67-5-6-70-80

|View full text |Cite

Immunogenicity of Vaccines Against SARS-CoV-2 In Patients With Rheumatic Diseases

Б. С. Белов

N. V. Muravyeva

A. N. Kulikov

Abstract: ВведениеВ течение последних двух лет особое внимание медицинского сообщества, включая ревматологов, привлечено к проблеме коронави-русной болезни 2019 (COVID-19, coronavirus disease 2019), этиологически связанной с вирусом SARS-CoV-2 (severe acute respiratory syndrome coronavirus-2). В качестве одного из методов борьбы с текущей пандемией COVID-19 боль-

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2023

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 59 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Rheumatoid arthritis and COVID-19: Three years later

Belov,

Aronova,

Gridneva

et al. 2023

Naučno-praktičeskaâ revmatologiâ

View full text Add to dashboard Cite

During the three years that have passed since the beginning of the COVID-19 pandemic, many new fundamental and medical problems have been discovered regarding the relationship between the viral infection and many common chronic non- infectious diseases. Among the latter, an important position is occupied by immuno-inflammatory rheumatic diseases (IIRD), which include rheumatoid arthritis (RA). To date, there is no doubt that patients with RA are at risk for SARS-CoV-2 infection, a severe course of infection that necessitates hospitalization and death. The article presents current data on the course and outcomes of COVID-19 in patients with RA. The literature and own data on postcovid syndrome in this group of patients are presented. The necessity of vaccination against SARS-CoV-2 in patients with IIRD, including those with RA, was substantiated. The prospects for further study of the features of COVID-19 in patients with RA are outlined.

show abstract

Rheumatoid arthritis and COVID-19: Three years later

Belov,

Aronova,

Gridneva

et al. 2023

Naučno-praktičeskaâ revmatologiâ

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

334 Leonard St

Brooklyn, NY 11211

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Immunogenicity of Vaccines Against SARS-CoV-2 In Patients With Rheumatic Diseases

Cited by 1 publication

References 59 publications

Rheumatoid arthritis and COVID-19: Three years later

Rheumatoid arthritis and COVID-19: Three years later

Contact Info

Product

Resources

About